Neonatal Thrombocytopenia Due to Dual Alloimmune and Autoimmune Mechanisms

J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e310-e312. doi: 10.1097/MPH.0000000000002352.

Abstract

Alloantibody-mediated and autoantibody-mediated immune destruction are common causes of early neonatal thrombocytopenia. The authors report a case of severe, early-onset thrombocytopenia with mucocutaneous bleeding in an otherwise well-appearing full-term neonate. Recurrence of thrombocytopenia following initial treatment and its persistence after 2 weeks of life suggested a dual immune mechanism. This is a rare case of immune thrombocytopenia caused by human platelet antigen-5b alloimmunization and passive transfer of maternal antiplatelet antibodies. Appropriate, timely treatment and absence of severe bleeding complications, namely intracranial hemorrhage, conferred a good overall prognosis.

Publication types

  • Case Reports

MeSH terms

  • Antigens, Human Platelet*
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases* / etiology
  • Infant, Newborn, Diseases* / therapy
  • Intracranial Hemorrhages / etiology
  • Isoantibodies
  • Purpura, Thrombocytopenic, Idiopathic* / complications
  • Purpura, Thrombocytopenic, Idiopathic* / therapy
  • Thrombocytopenia, Neonatal Alloimmune* / etiology
  • Thrombocytopenia, Neonatal Alloimmune* / therapy

Substances

  • Antigens, Human Platelet
  • Isoantibodies